ClinVar Miner

Submissions for variant NM_001277115.2(DNAH11):c.8888C>A (p.Ser2963Tyr)

gnomAD frequency: 0.00047  dbSNP: rs374033085
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 5
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000289296 SCV000468167 uncertain significance Primary ciliary dyskinesia 2016-06-14 criteria provided, single submitter clinical testing
Invitae RCV000289296 SCV000624181 benign Primary ciliary dyskinesia 2024-01-31 criteria provided, single submitter clinical testing
Genetics and Molecular Pathology, SA Pathology RCV002272215 SCV002556526 uncertain significance Primary ciliary dyskinesia 7 2019-10-10 criteria provided, single submitter clinical testing
Ambry Genetics RCV000289296 SCV002687323 uncertain significance Primary ciliary dyskinesia 2014-06-04 criteria provided, single submitter clinical testing The p.S2970Y variant (also known as c.8909C>A), located in coding exon 54 of the DNAH11 gene, results from a C to A substitution at nucleotide position 8909. The serine at codon 2970 is replaced by tyrosine, an amino acid with dissimilar properties. This variant was previously reported in the SNPDatabase as rs374033085. Based on data from the NHLBI Exome Sequencing Project (ESP), the A allele has an overall frequency of approximately 0.0 4% (5/11956) total alleles studied and 0.06% (5/8210) European American alleles. This variant was not identified in the homozygous state in 5,978 individuals studied. This amino acid position is conserved through mammals, but not in lower vertebrate species. In addition, this alteration is predicted to be probably damaging and deleterious by PolyPhen and SIFTin silicoanalyses, respectively. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear.
CeGaT Center for Human Genetics Tuebingen RCV003437126 SCV004163807 likely benign not provided 2023-09-01 criteria provided, single submitter clinical testing DNAH11: BP4

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.